Highest-materiality recent filing
Enovis Q1 net sales up 5% to $589M, net loss $8M; reaffirms FY2026 guidance
Q1 net sales $589M (+5% reported, +3% organic); Recon sales +11% reported, P&R flat.
Enovis posts FY2025 net loss of $1.18B including $1.05B goodwill impairment; Q4 sales $576M
Full-year 2025 net sales $2.2B, up 7% reported/6% organic; Recon sales +10%, P&R +4%.
Enovis amends credit agreement; extends maturity to 2030, upsizes cash offset to $400M
Amended credit agreement provides $1.1B revolver and $700M term loan, both maturing Dec 8, 2030.
Enovis Q3 sales up 9% to $549M; raises FY adjusted EBITDA and EPS guidance
Q3 net sales $549M (+9% reported, +7% organic); Recon +12% reported, P&R +6% reported.
Enovis Q2 revenue up 7%, guided FY25 higher; adjusted EPS $0.79
Net sales $565M (+7% reported, +5% organic); Recon +11%, P&R +5%.
Enovis Q1 revenue +8% to $559M; adjusted EBITDA margin 17.7% (+160bps); appoints Damien McDonald CEO
Q1 net sales $559M, +8% reported; Recon +11%, P&R +5% YoY.
Enovis appoints Damien McDonald as CEO effective May 12; Q1 guidance reaffirmed
Damien McDonald, former LivaNova CEO, appointed CEO effective May 12, 2025; succeeds retiring CEO Matt Trerotola.
CEO Matthew Trerotola's retirement effective when successor appointed; transition agreement signed March 13, 2025.
Enovis CEO Matt Trerotola to retire; board begins search for successor
CEO Trerotola retiring upon successor appointment; will serve as Executive Advisor for one year.
Enovis Q4 net loss $704M on $645M goodwill impairment; CEO plans retirement
Q4 revenue $561M (+23% reported, +6% comparable); Recon sales +59% reported.
Q3 net sales $505M, up 21% reported/6% comparable; Recon sales +57% reported/9% comparable.
Enovis Q2 sales up 23% to $525M; raises adjusted EPS guidance to $2.62-$2.77
Q2 net sales $525M (+23% reported, +5% comparable); Recon sales +60% reported.
Enovis Q1 revenue $516M (+27% YoY), adjusted EPS $0.50, raises full-year outlook
Net sales of $516M, up 27% reported and 5% proforma YoY; Recon sales +66% reported, +7% proforma.
Enovis Q4 sales $455M +11% YoY; FY2024 guidance $2.05-2.15B revenue
Q4 2023 net sales $455M (+11% YoY, organic +8%); net income $3M ($0.05 GAAP EPS), adjusted EPS $0.79.
Enovis files Lima financials post-acquisition: 2022 revenue €245.7M, net loss €19.3M
Acquired 100% of LimaCorporate S.p.A. on Jan 3, 2024 from Emil Holding II S.à r.l.
Enovis Corp closes acquisition of LimaCorporate for ~€727M cash plus 1.94M shares
Completed acquisition of LimaCorporate on Jan 3, 2024 for ~€726.8M cash plus 1,942,686 shares valued at €100M.
Enovis COO Brady Shirley to retire by Q1 2025; Vogt and Ross promoted to Group Presidents
Brady Shirley to step down as President and COO on April 1, 2024, become Executive Advisor focused on Lima integration until retirement end of Q1 2025.
Enovis Q3 sales $418M (+9% YoY), adj EPS $0.56; raises full-year outlook
Q3 net sales $418M, +9% YoY; net loss from cont ops $19M ($0.36 loss per share).
$460M 3.875% convertible notes due Oct 2028 issued; net proceeds ~$445.1M after fees.
Enovis prices $400M of 3.875% convertible notes due 2028 to fund Lima acquisition
Priced $400M aggregate principal of 3.875% Convertible Senior Notes due 2028; initial purchasers option for additional $60M.
Enovis Q3 prelim revenue $414-$418M, adj EBITDA $64-$66M, +8-9% and +12-15% YoY
Q3 revenue expected $414-$418M vs $383M prior year (+8-9%); adj EBITDA $64-$66M vs $57M (+12-15%).
Enovis agrees to acquire LimaCorporate for ~€800M enterprise value
Enterprise value ~€800M: ~€700M cash at closing plus 1,942,686 Enovis shares valued at €100M.
Enovis to acquire LimaCorporate for €800M enterprise value
Enterprise value €800M: €700M cash at closing + €100M in Enovis common shares within 18 months.
Enovis Q2 sales up 8% to $429M; raises full-year guidance on organic growth and margin expansion
Q2 net sales $429M, +8% YoY; organic sales per day growth 9%.
Enovis Q1 net sales $406M (+9% organic), adj EPS $0.44; raises FY2023 outlook
Recon segment organic growth 19% (P&R +4%); total organic sales +9%.
Q4 net sales $409M (+2% YoY, +5% organic); Reconstructive segment organic growth 14%.
Enovis exchanges retained ESAB shares for $230.5M of term loan debt
On Nov 18, 2022, Enovis exchanged 6,003,431 ESAB shares (all retained) for $230,531,750.40 of term loan.
Enovis Q3 revenue $384M (+7% organic), adj EPS $0.59 (+34% YoY), guides FY adj EPS $2.20-$2.25
Reconstructive segment revenue $127M (+15% organic); Prevention & Recovery $257M (+4% organic).
Enovis Q2 revenue $395M (+11%), adjusted EPS $0.59 (+44%), full-year guidance updated
Reported EPS from continuing ops $2.21; adjusted EPS $0.59 vs $0.41 YoY, includes ~$0.10 one-time tax benefit.
Enovis announces CFO transition: Hix to retire, Berry to succeed Jan 1, 2023
Chris Hix to retire as CFO on Dec 31, 2022; will remain as advisor until late 2023.
Enovis reports Q1 adjusted stand-alone sales up 21% to $375M, EBITDA up 25%
Sales of $375M (+21% total, +7% organic); Recon +72% (+12% organic), P&R +4% (+6% organic).
Enovis completes ESAB spin-off; new $1.8B credit facility; board refreshed
On April 4, 2022, Enovis distributed 90% of ESAB shares: 1 ESAB per 3 Enovis shares; retained 10%.
appointed Mr. McDonald as a member of the Board to fill the vacancy resulting from Mr. Trerotola’s retirement from the Board.
the Board has (i) appointed Sharon Wienbar, who has served as the Lead Independent Director of the Board since May 2023, to serve as independent Chair of the Board
Matthew L. Trerotola, the Company’s current CEO, will retire from such role as of the Appointment Date
the Board of Directors of the Company (the “Board”) has appointed Damien McDonald as Chief Executive Officer (“CEO”) of the Company, effective as of May 12, 2025
As previously announced by Enovis Corporation (the “Company”), on February 25, 2025, Matthew L. Trerotola notified the Board of Directors (the “Board”) of the Company of his intention to retire from his current position as Chief Executive Officer (“CEO”) of the Company, effective upon his successor being appointed by the Board and assuming the position as CEO of the Company (the “Appointment Date”).
On February 25, 2025, Matthew L. Trerotola notified the Board of Directors (the “Board”) of Enovis Corporation (the “Company”) of his intention to retire from his current position as Chief Executive Officer (“CEO”) of the Company, effective upon his successor being appointed by the Board and assuming the position as CEO of the Company.
Effective as of April 1, 2024, Mr. Shirley will step down from his current position as President and Chief Operating Officer and assume the role of Executive Advisor, focusing on ensuring the successful integration of the Company’s pending acquisition of LimaCorporate S.p.A. and mentoring the Company’s business leaders until his eventual transition to retirement
Matthew L. Trerotola, the Company’s Chief Executive Officer and a current director, will become Chair of the Board
Mitchell P. Rales notified the Board of Directors (the “Board”) of Enovis Corporation (the “Company”) that he will not stand for re-election as a director and will retire from the Board upon the expiration of his term at the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”) on May 16, 2023.
independent director Sharon Wienbar will become Lead Independent Director
the Company’s board of directors appointed Phillip Benjamin (Ben) Berry as the Company’s new Chief Financial Officer and principal financial officer, effective as of January 1, 2023
Christopher M. Hix retired from his position as the Company’s Executive Vice President and Chief Financial Officer and ceased to serve as the Company’s principal financial officer on December 31, 2022
Max materiality 0.85 · Median 0.68 · Most common event earnings